Although HAS3 appears to play a dominant role in oral cancer, we still can not rule out the involvement of HAS1 or HAS2 in HA synthesis nor explain why reduced HA staining was a poor prognositic maker in other oral cancer cohort [20]. The gene discussed is HAS2; the disease is lip and oral cavity carcinoma.